Time to change the stock portfolio from glove to energy counter. Cut lost here and move there to recover. All energy counter start to sky rocket this week and will continue next week. Bye2 for now LKL,..
Two fatalities were found in Sabah, while one each was detected in Johor and Selangor. The deceased — involving four men — were aged between 46 and 75 years with several health complications such as high blood pressure, asthma, diabetes, and stroke.The number of active cases, which carry high transmission risks, dropped slightly to 10,775 from 10,799 reported yesterday.Currently, 130 patients are being treated in intensive care units, with 54 needing ventilators.
Health budget allocation will benefit this counter. After Covid, private and public hospitals will be forced to refurbish because the stigma related to beds and equipment used for Covid red zones in hospitals. Word will travel fast and furious which hospital has "cleaned up" their rooms with new beds, replacing those used for Covid wards. Then you will see orders come in to LKL.
UAE says Sinopharm vaccine has 86% efficacy against COVID-19
DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.
The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.
“The analysis shows no serious safety concerns,” it said.
It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.
United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19
TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.
The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.
The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.
The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”
The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.
sunshine, but it seems will drop below 0.9, unless a strong rebound next week I feel that glove and medical counter theme play has ended at the moment. Everytime rebound but then drop further. The stocks has lost its momentum at least for now.
As u can see top glove announced superb result, and yet the price going south, it shows all the positive elements already factor in. Maybe operators know this kind of result wont repeat again in the future and they start to sell off and most of the ppl in the market also follow.
Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight
Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans
Bahrain approved the registration of the Sinopharm Group Co Ltd. vaccine against the coronavirus, about a week after the United Arab Emirates registered the Chinese-made vaccine.
“Results from Phase III clinical trials showed an 86% efficacy rate, a 99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of Covid-19,” the National Health Regulatory Authority said in a statement Sunday.
Bahrain has participated in phase III clinical trials, in which more than 7,700 volunteers signed up. Bahrain had previously authorized the emergency use of the vaccine, which was provided to frontline workers in contact with coronavirus patients.
The UAE registered the Sinopharm vaccine after finding it had a 86% efficacy rate, paving the way for a full public use and allowing for a re-opening of the Gulf nation’s economy.
Egypt plans to start the process of inoculation against the coronavirus after receiving the first shipments of Sinopharm vaccine.
Govt to increase Covid-19 vaccine purchase to cover 60%-70% of M'sians — PM
The government has plans to increase its purchase of the Covid-19 vaccine to cover the immunisation needs of about 60%-70% of Malaysians compared with 30% currently.
Prime Minister Tan Sri Muhyiddin Yassin said this was because some nations had purchased doses exceeding their population.
“As for Malaysia, we have already got 30%. I have instructed Health Minister Datuk Seri Dr Adham Baba along with [Science, Technology and Innovation Minister] Khairy Jamaluddin Abu Bakar to negotiate and increase it from 30% to 60% or 70%.
COVID-19 vaccine is permissible for Muslim use, preservation of life is key consideration: MUIS
SINGAPORE: The Islamic Religious Council of Singapore (MUIS) said on Sunday (Dec 13) that it "holds the position that a COVID-19 vaccine is permissible for Muslim use".
"We would advise and encourage Muslims to be vaccinated once it is available and when the vaccine has been medically authorised as safe and effective, as this is a basic necessity to protect lives in the context of a global pandemic," said MUIS.
The council made its religious position on the vaccine known in a media release.
It said that the objectives of introducing a COVID-19 vaccine and the processes involved in producing vaccines are "largely aligned to established Islamic principles and values".
Islamic jurisprudence places great importance on the sanctity and safety of human life and the protection of livelihoods, it said.
Efforts to protect human life from any form of danger and harm, such as the development of vaccines, are therefore highly encouraged in Islam, it added.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
kens88
698 posts
Posted by kens88 > 2020-12-02 17:19 | Report Abuse
Stay away from all stocks better